NCT04671901 2025-05-28
A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated
Clinical Trials
8 trialsNCT04478123 2024-02-14
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT04427306 2023-09-15
Neoadjuvant T-VEC in High Risk Early Melanoma
University of California, Davis
Phase 2 Suspended
NCT01516619 2022-08-12
ProRom
IRCCS San Raffaele
Phase 2 Completed
NCT03622931 2021-02-08
TRACEII
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Phase 2 Terminated
NCT01676961 2018-10-15
Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy
NYU Langone Health
Phase 2 Terminated
NCT02227576 2018-04-25
PLATUM
University Hospital, Lille
Phase 2 Terminated
NCT00413283 2013-10-24
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Amgen
Phase 2 Completed